Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Soiken Holdings's share price for the quarter that ended in Dec. 2025 was 円235. Soiken Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 26 Mil. Therefore, Soiken Holdings's market cap for the quarter that ended in Dec. 2025 was 円6,147 Mil.
Soiken Holdings's quarterly market cap
increased
from Mar. 2025 (円3,845 Mil) to Jun. 2025 (円4,395 Mil) and
increased
from Jun. 2025 (円4,395 Mil) to Dec. 2025 (円6,147 Mil).
Soiken Holdings's annual market cap
declined
from Jun. 2023 (円7,847 Mil) to Jun. 2024 (円4,368 Mil) but then
increased
from Jun. 2024 (円4,368 Mil) to Jun. 2025 (円4,395 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Soiken Holdings's Enterprise Value for Today is 円-177 Mil.
Soiken Holdings (TSE:2385) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Soiken Holdings Market Cap Related Terms
Soiken Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Soiken Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2385 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Soiken Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soiken Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Soiken Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Soiken Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Soiken Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Soiken Holdings (TSE:2385) has a Market Cap of 円5,467 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Soiken Holdings and its competitors. According to the industry distribution chart, Soiken Holdings ranks #986 out of 1422 companies in the Biotechnology industry, placing it in the top 69.3%.
Is Soiken Holdings' Market Cap too high?
Soiken Holdings' current Market Cap is 円5,467 Mil. Based on the distribution chart, Soiken Holdings ranks #986 out of 1422 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Soiken Holdings has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Soiken Holdings ranks #986 out of 1422 companies for Market Cap. This places Soiken Holdings in the lower half of its industry. The industry median Market Cap is 121.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.26, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Soiken Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 121.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Soiken Holdings's current Market Cap is 円5,467 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円114.55, compared to a current price of 円209.00 — trading 82.5% above its estimated fair value. The current Market Cap is 円5,467 Mil. Soiken Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Market Cap is 円5,467 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soiken Holdings (TSE:2385) Overvalued in 2026?
Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued.
The current stock price of 円209.00 is trading 82.5% above its estimated GF Value™ of 円114.55.
GuruFocus considers Soiken Holdings to be Significantly Overvalued.
Key valuation signals for TSE:2385:
Market Cap: 円5,467 Mil
GF Value™: 円114.55 vs. price of 円209.00 (82.5% above fair value)
No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
56GF Score
Get the complete analysis for TSE:2385
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2385 has been successfully added to your 
